Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
164.5 EUR | +2.68% | +1.55% | +13.88% |
Mar. 26 | UBS Raises Merck KGaA PT, Keeps Buy Rating | MT |
Mar. 26 | MERCK KGAA : Jefferies keeps its Buy rating | ZD |
Sales 2024 * | 21.28B 22.99B | Sales 2025 * | 22.54B 24.35B | Capitalization | 69.65B 75.24B |
---|---|---|---|---|---|
Net income 2024 * | 2.96B 3.2B | Net income 2025 * | 3.44B 3.72B | EV / Sales 2024 * | 3.55 x |
Net Debt 2024 * | 5.92B 6.4B | Net Debt 2025 * | 3.96B 4.27B | EV / Sales 2025 * | 3.27 x |
P/E ratio 2024 * |
23.7
x | P/E ratio 2025 * |
20.1
x | Employees | 62,908 |
Yield 2024 * |
1.39% | Yield 2025 * |
1.51% | Free-Float | 29.71% |
Latest transcript on Merck KGaA
1 day | +0.53% | ||
1 week | +2.46% | ||
Current month | +1.52% | ||
1 month | +1.49% | ||
3 months | +12.18% | ||
6 months | +2.96% | ||
Current year | +11.17% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 20-07-12 | |
Director of Finance/CFO | 53 | 19-04-25 | |
Laura Matz
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 75 | 14-05-08 | |
Chairman | 67 | 19-04-25 | |
Jürgen Glaser
BRD | Director/Board Member | 61 | 12-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.34% | 2 M€ | +13.56% | - | |
2.01% | 0 M€ | 0.00% | - | |
1.80% | 962 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 164.1 | +2.43% | 74 931 |
24-03-27 | 160.2 | +0.69% | 299,813 |
24-03-26 | 159.1 | -0.31% | 255,538 |
24-03-25 | 159.6 | -1.36% | 165,432 |
24-03-22 | 161.8 | +0.12% | 209,833 |
Delayed Quote Xetra, March 27, 2024 at 12:35 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.17% | 75.36B | |
+14.56% | 9.82B | |
-5.68% | 5.49B | |
+10.90% | 4.21B | |
+16.55% | 3.66B | |
+43.88% | 2.93B | |
-18.99% | 2.54B | |
-21.20% | 2.35B | |
+16.59% | 1.85B | |
-0.50% | 1.64B |